🇿🇲Vishal C Patel🇬🇧
@DrVishalCPatel
Followers
1K
Following
2K
Media
27
Statuses
670
Hepatologist🏥@KingsCollegeNHS | ACLD Group Lead Microbiome🧫🦠 cfDNA🧬@Inst_of_Hep | Adjunct Reader in Hepatology @kingsmedicine🖋️ | @BoppPtrial💊| Home=🇿🇲
London, England
Joined April 2019
Oral👄↔️gut💩#microbiome 🧫🦠 overlap🔃 in chronic liver disease #cirrhosis | virulence factors🌡️ | antimicrobial resistance #AMR 🧬 @Inst_of_Hep
@KCH_Research
@KingsCollegeNHS
@KCLImmunoMicro
@supportkings
@scilifelab
@BritSocGastro
@EASLnews
@clecliniclondon
@MicrobPredict
🆕Article in press❕ Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance #OpenAccess here👉 https://t.co/U6uRUxP6q9
#LiverTwitter
1
19
37
New online! Mechanistic insights into the liver–brain axis during chronic liver disease https://t.co/3mhinTyyrX
1
43
123
The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, which Drs. Laurent Castera, Mary E. Rinella, and Emmanuel A. Tsochatzis review.
5
344
1K
A big day for liver health in @UKParliament. Today’s debate on obesity and fatty liver disease (MASLD) is a step in our fight for better prevention, diagnosis and treatment. We're proud to have worked with @LiverTrust to ensure liver health remains high on the national agenda.
0
4
10
💊+📷= Medicine. In our latest @TheLancetLongevity paper we argue: 👉 “Exercise prescription is medically indicated, professionally implemented, and clinically monitored.” It’s time to integrate exercise into medication management for older adults. Read here ➡️
4
120
332
🟣 9/14 | BASL × FG Special Issue “Malnutrition and frailty affect up to 80% of patients with decompensated cirrhosis.” ⚠️ Both double the risk of hospitalisation and mortality 🧪 Tools like LFI, DASI, MAMC & HGS enable early identification 🤝 MDT prehabilitation (nutrition,
0
11
33
After 10 happy years of training in Oxford, it's time for something new Delighted to be joining the @Inst_of_Liver at @kingsmedicine Cant wait to join such an amazing team @phil_newsome7 @AHadjihambi @DebbieShawcros1 @DrVishalCPatel @DrAntonioRiva @MichaelHenegha8 @foad_rouhani
Exciting news from @kingsmedicine & @f4liverresearch. Dr @tom_marjot has been appointed to the new King’s College Roger Williams Fellowship in Hepatology at the Roger Williams Institute of Liver Studies. Joining from the University of Oxford in April 2026, Tom’s research will
18
11
82
Exciting news from @kingsmedicine & @f4liverresearch. Dr @tom_marjot has been appointed to the new King’s College Roger Williams Fellowship in Hepatology at the Roger Williams Institute of Liver Studies. Joining from the University of Oxford in April 2026, Tom’s research will
kcl.ac.uk
Dr Thomas Marjot DPhil, MRCP will hold the King’s College Roger Williams Fellowship in Hepatology and an Honorary Consultant Hepatologist position. He will take up the post in April 2026, joining the...
5
2
24
We are delighted to share the programme highlights for the upcoming Introduction to Research Day for @BSGNurses & @BSGTrainees🔍 taking place 29th November Register now at https://t.co/yqdANLdBA3
0
5
7
@schirmer_lab @Inst_of_Liver @KCH_Research @KingsCollegeNHS @KCLImmunoMicro @NIHRresearch @BritSocGastro @EASLnews @clecliniclondon @MicrobPredict This work is underpinned by a fantastic UK-Germany collaboration🤝 with @schirmer_lab, with the incredibly talented PhD student @ShenJin_AuAs driving together with @AurelieCenier, and Naiara Beraza @TheQuadram, working with our research group @Inst_of_Hep @KCLImmunoMicro. 🤩🤗
0
0
4
Oral microbiome 👅🧫 = a robust biomarker (auPR=0.91) in advanced chronic liver disease & therapeutic target 🦷 @schirmer_lab
@Inst_of_Liver
@KCH_Research
@KingsCollegeNHS
@KCLImmunoMicro
@NIHRresearch
@BritSocGastro
@EASLnews
@clecliniclondon
@MicrobPredict
#LiverTwitter
1
0
4
🚨 New preprint 🚨 In cirrhosis, oral👄 microbes (Veillonella, Streptococcus) translocate ↘️ gut, carry a collagenase-like enzyme (prtC), disrupt⛓️💥 the intestinal barrier & ⬆️ hepatic fibrosis 🧬 https://t.co/TlKm0YwlRi
biorxiv.org
While microbiome perturbations are associated with advanced chronic liver disease (ACLD), microbial disease mechanisms are poorly understood. Using multi-omics analyses of paired saliva and faecal...
2
3
7
🌟 Hepatology nurses & AHPs (dietitians, physios) are GAME CHANGERS in liver care! 💪🩺 They boost patient outcomes, cut admissions & save costs—but remain underfunded & overlooked. 🚨 This new paper in @FrontGastro_BMJ by @Lynsey_RD highlights challenges & calls for: ✅
1
14
26
The 5th King’s Liver Intensive Care Conference. A fabulous 2 day programme and incredible speakers in the world of liver intensive care, and liver transplantation from King’s College London. Accredited for 12 CPD points from RCoA. Limited spaces so don’t miss out!
3
6
13
Check out the programme of the 3rd International Workshop on Liver and Gut Fibrosis. 16-17 Oct, VALENCIA https://t.co/XJ3Kye0PBQ
#fibrosisvlc #LiverGutFibrosis25 #livertwitter #IBD
0
5
9
📢📢POST-DOC JOB VACANCY 📢📢 We're currently hiring for a Postdoctoral Scientist to join our Liver Regeneration & Tissue Engineering group with @UrbaniLab! Follow the link below for more info and to apply today 🧪👩🔬🔬 https://t.co/guTy3YflPX
#ScienceCareers #STEMcareers
0
10
9
Excited to be presenting the Early Career Researcher talk at this week’s @TARGet_AMR webinar!
🚀3 Days to Go - the countdown is ON!🚀 🎤🔬Featuring Professor Matthew Holden - diving into Genomics and Beyond: A Holistic Approach to understanding AMR in East Africa🌍🦠 📅20th March ⏰12:00 PM GMT 💻Teams – Register now! 👇 https://t.co/FBFeaw2dMH
0
1
14
Calling all @BSGTrainees @BASLedu @basl_events @ResearchBsg Save the Date! BASL Rare Liver Diseases Masterclass. Sun - Mon 15-16th June 2025 Central London Focus on Wilson's Disease, Alpha-1 antitrypsin, Iron disorders, Cholestatic liver disease and more. @DrVishalCPatel
0
6
7
Forthcoming BALTI ascites course for Nurses & confirmed programme ! Places available ..please let colleagues know. One of the the few courses (that we know of) of its kind and regular good feedback.. @SaraBardell @JoMcDonagh2 @Drfattyliver @UHBTherapy @uhbtrust @UHBEducation
1
11
16
Very proud to have this published! Thank you to the Lancet and it’s incredible editorial team for your collaboration on this project. Some important updates, hope you find it useful! Appendix has lots of information about pregnancy in AIH, PBC, PSC and Wilson’s too.
Physiological changes that occur in pregnancy can exacerbate or improve some pre-existent liver diseases. A new Review describes the challenges of diagnosing, risk stratifying, and managing liver disease in pregnancy: https://t.co/RG4k6LY0ZK
4
14
35
Physiological changes that occur in pregnancy can exacerbate or improve some pre-existent liver diseases. A new Review describes the challenges of diagnosing, risk stratifying, and managing liver disease in pregnancy: https://t.co/RG4k6LY0ZK
1
51
130